Medicare Enrolled

Brittany Whitman, PA-C

Medical Physician Assistant · Pensacola, FL
9290 BALDRIDGE RD, Pensacola, FL 32514
8504720123
Registered in NPPES since 2014
NPI: 1952717969 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Whitman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Whitman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Whitman

Brittany Whitman is a medical physician assistant in Pensacola, FL, with 12 years of NPI registration.

Between the years covered by Open Payments, Whitman received a total of $6,632 from 50 pharmaceutical and/or device companies across 441 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Whitman is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years of NPI registration $6,632 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,632
Total received (2021-2024)
Avg $1,658/year across 4 years
Top 7% in FL for medical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
441
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,555
2023
$1,670
2022
$1,702
2021
$1,705

Payments by company (2024)

Novo Nordisk Inc
$372
ABBVIE INC.
$234
PFIZER INC.
$216
Axsome Therapeutics, Inc.
$87
Sumitomo Pharma America, Inc.
$87
Bayer Healthcare Pharmaceuticals Inc.
$85
GlaxoSmithKline, LLC.
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
Lilly USA, LLC
$57
Teva Pharmaceuticals USA, Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$46
AstraZeneca Pharmaceuticals LP
$35
Novartis Pharmaceuticals Corporation
$33
Exact Sciences Corporation
$31
Otsuka America Pharmaceutical, Inc.
$28
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Phathom Pharmaceuticals, Inc.
$17
Corcept Therapeutics
$14
Top 3 companies account for 52.9% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$1,194
ABBVIE INC.
$744
PFIZER INC.
$593
GlaxoSmithKline, LLC.
$458
Lilly USA, LLC
$309
AbbVie Inc.
$299
Axsome Therapeutics, Inc.
$270
Boehringer Ingelheim Pharmaceuticals, Inc.
$254
Lundbeck LLC
$212
Amgen Inc.
$208
Bayer Healthcare Pharmaceuticals Inc.
$178
Supernus Pharmaceuticals, Inc.
$163
Takeda Pharmaceuticals U.S.A., Inc.
$154
Bayer HealthCare Pharmaceuticals Inc.
$129
Janssen Pharmaceuticals, Inc
$116
UPSHER-SMITH LABORATORIES LLC
$87
Sumitomo Pharma America, Inc.
$87
AstraZeneca Pharmaceuticals LP
$76
Sunovion Pharmaceuticals Inc.
$76
JAZZ PHARMACEUTICALS INC.
$75
Astellas Pharma US Inc
$72
Teva Pharmaceuticals USA, Inc.
$72
Biohaven Pharmaceuticals, Inc.
$68
Exact Sciences Corporation
$61
SANOFI-AVENTIS U.S. LLC
$60
Kowa Pharmaceuticals America, Inc.
$58
Dexcom, Inc.
$56
Novartis Pharmaceuticals Corporation
$53
Esperion Therapeutics, Inc.
$49
Biohaven Pharmaceutical Holding Company Ltd.
$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
Otsuka America Pharmaceutical, Inc.
$28
DEXCOM, INC.
$23
Tris Pharma Inc
$21
Avanir Pharmaceuticals, Inc.
$20
Abbott Laboratories
$20
Amarin Pharma Inc.
$18
Medtronic, Inc.
$17
EISAI INC.
$17
Merck Sharp & Dohme LLC
$17
Phathom Pharmaceuticals, Inc.
$17
Adlon Therapeutics L.P.
$17
PBG PUERTO RICO LLC
$17
Bausch Health US, LLC
$16
Clarus Therapeutics Inc.
$15
Allergan, Inc.
$15
Ironshore Pharmaceuticals Inc.
$14
Corcept Therapeutics
$14
Neos Therapeutics, LP
$13
Paratek Pharmaceuticals, Inc.
$13
Top 3 companies account for 38.1% of all-time payments
Associated products mentioned in payments ›
ADHANSIA XR · AIRSUPRA · AJOVY · APLENZIN · Adzenys XR-ODT · Aimovig · ArmonAir Digihaler · Auvelity · COMIRNATY · CREON · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · Dyanavel XR · ELIQUIS · EMGALITY · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · GEMTESA · JARDIANCE · JATENZO · JORNAY PM · Kerendia · Korlym · LEQVIO · LINZESS · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NA · NEXLETOL · NURTEC ODT · NUZYRA · Nuedexta · OXTELLAR XR · Otezla · Ozempic · PAXLOVID · PREMARIN · PREVNAR 13 · PREVNAR 20 · QELBREE · QULIPTA · REXULTI · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYNTHROID · Sunosi · TOSYMRA · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · VYEPTI · VYVANSE · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical physician assistant in Pensacola?
Compare medical physician assistants in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical physician assistants in nearby ZIP areas
74
County median income
$65,715
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA WEST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Whitman is a medical physician assistant.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Whitman receive payments from pharmaceutical companies?
Yes. Whitman received a total of $6,632 from 50 companies across 441 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Whitman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →